Jump Financial, LLC Gritstone Bio, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.45 - $0.71 $5,542 - $8,744	-12,316 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$0.62 - $2.35 $7,635 - $28,942	12,316 New	12,316 $7,000
Q1 2023 Oct 21, 2024	BUY	$2.13 - $3.74 $52,402 - $92,011	24,602 Added 199.76%	36,918 $102,000
Q1 2023 May 03, 2023	BUY	$2.13 - $3.74 $44,470 - $78,083	20,878 Added 130.16%	36,918 $102,000
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $34,806 - $62,876	16,040 New	16,040 $55,000
Q2 2022 Aug 09, 2022	SELL	$1.77 - $4.34 $75,048 - $184,016	-42,400 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$4.03 - $12.19 $170,872 - $516,856	42,400 New	42,400 $175,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.